Procedures for monitoring recombinant erythropoietin and analogs in doping.
Hemoglobin concentration is one of the principal factors of aerobic power and, consequently, of performance in many types of physical activities. The use of recombinant human erythropoietin is, therefore, particularly powerful for improving the physical performances of patients, and, more generally, improving their quality of life. This article discusses procedures for monitoring recombinant erythropoietin and its analogues in doping for athletic performance.
Lamon
Séverine
S
Swiss Laboratory for Doping Analyses, University Center of Legal Medicine, West Switzerland, Epalinges, Switzerland.
Robinson
Neil
N
Saugy
Martial
M
D054874:Athletic Performance / Q000502:physiology; D004300:Doping in Sports / Q000266:history / Q000517:prevention & control*; D004921:Erythropoietin / Q000008:administration & dosage* / Q000032:analysis*; D005189:False Positive Reactions; D006400:Hematocrit; D006454:Hemoglobins / Q000032:analysis; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D007118:Immunoassay; D007525:Isoelectric Focusing / Q000592:standards; D010101:Oxygen Consumption / Q000187:drug effects; D011994:Recombinant Proteins
D006454:Hemoglobins; D011994:Recombinant Proteins; D004921:Erythropoietin